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INTRODUCTION
We report a 2-year (2004–2005) prospective study
of the incidence, epidemiology and clinical man-
ifestations of Q fever among patients in northern
Greece.
MATERIALS AND METHODS
Serum samples from 850 patients suspected to be infected by
C. burnetii were examined for the presence of antibodies
against phase I and II of the microorganism. The study
population was composed of people 1–70 years old, living in
the rural and urban areas of the 16 prefectures in northern
Greece. Characteristics of the patients were collected, includ-
ing age, sex, underlying disease, occupation, contact with
animals, and consumption of unpasteurised products.
One serum sample was obtained at the time of admission
and a second one 4 weeks later. All sera were examined using
the IFA test (Focus) and the ELISA assay (Serion) according to
the manufacturer’s instructions. The samples found to be
positive to C. burnetii were also examined for Legionella
pneumophila, Bartonella and Chlamydia species in order to
exclude cross-reactivity.
RESULTS
Acute Q fever was diagnosed in 57 (6%) patients,
based on the detection of IgM antibodies 1–
2 weeks after the onset of the symptoms. Sero-
conversion was considered to be diagnostic of Q
fever and was determined in almost all cases. One
chronic case, an endocarditis fulﬁlling the Duke
criteria, was detected (Table 1).
Most cases, 76%, were diagnosed from January
through to May. The male to female ratio was 2:1.
The mean age of the patients was 45 ± 5 years. No
acute or chronic form of the infection was
detected in patients younger than 17 years of
age. Acute Q fever was diagnosed in none of the
182 patients younger than 14 years of age, in 3.1%
of patients between 15 and 29 years of age, in
8.4% of patients between 30 and 50 years of age,
in 9.3% of patients aged between 50 and 70, and
in 5.2% of patients older than 70 years of age.
The mean time from the onset of symptoms to
admission was 8 days. One patient had a history
of valvulopathy and three had a history of immu-
nodeﬁciency. Forty patients (69%) had a history of
contact with animals, mainly with sheep. Forty-
three patients (74.2%) lived in rural areas and 15
(25.8%) patients in urban areas. Seven patients
had consumed unpasteurised products.
Most patients were treated with doxycycline or
tetracycline and recovered completely. Only two
patients, who were signiﬁcantly older and more
immunocompromised, died eventually.
DISCUSSION
Although described years ago, Q fever is still a
poorly understood disease [1]. The main charac-
teristic is its clinical polymorphism. Following
primary infection half of the patients remain
asymptomatic [2]. Among those who are symp-
tomatic, acute Q fever typically presents as a self-
limited febrile illness, pneumonia or hepatitis.
Over recent years rare clinical manifestations such
as osteomyelitis, optic neuritis, pericarditis, lym-
phathenopathy and Guillain-Barre have increas-
ingly been reported. Endocarditis is the
predominant form of chronic Q fever and mostly
affects patients with underlying valvulopathy [2].
Our study was undertaken in rural and urban
areas to investigate the incidence and epidemio-
logical and clinical aspects of Q fever. Diagnosis
was based upon serology, with phase I and phase
II antibodies distinguishing acute from chronic
disease.
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The predominant clinical manifestations were
pneumonia, ﬂu-like syndrome and hepatitis,
whereas lymphadenopathy, pericarditis, Guil-
lain-Barre, osteomyelitis and optic neuritis were
the dominant features in only a minority of
patients. Endocarditis was the only chronic case.
Q fever in children was not reported.
Individuals aged between 30 and 50 years
appeared to have an increased risk of infection.
This age-related increase of the incidence and
severity of infection is also evident in other surveys
andmaybe attributed tomore frequent exposure to
farm animals and pets, through travel to the
countryside and involvement in outdoor activities.
Most cases occurred during winter and spring.
Lambing occurs during winter and early spring
and may explain the increased incidences during
that time. Contact with animals and consumption
of unpasteurised products were found to be risk
factors in the acquisition of Q fever [3]. It is
common in urban areas of Greece, even nowa-
days, that unpasteurised milk and cheese are
distributed directly from stock-breeders and
farmers to consumers.
Men and women were not equally represented
(2:1) and this could be explained by the fact that
men are more involved in farming [2]. It is also
possible that female hormones may have a pro-
tective role [4].
Almost all patients were treated with the
reference standard for treatment (doxycycline or
tetracycline) and recovered completely.
Q fever in northern Greece has been reported in
the past. In 1946, Caminopetros detected the
microorganism in sera of German soldiers. Since
then surveys from Crete [5] and northern Greece
have reported epidemiological, clinical and ther-
apeutic data of Q fever. Reports from France,
Spain and Italy indicate that epidemiological and
clinical features of the disease may vary from one
area of south Europe to another. In north Europe
Q fever is less frequently reported and is not
included in the list of nationally notiﬁable dis-
eases.
Our data indicate that Q fever should be
considered a public health problem with several
clinical manifestations and we recommend that
patients with epidemiological risk factors for
infection with C. burnetii should undergo serolog-
ical testing for Q fever.
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Table 1. Clinical manifestations of Q fever
Manifestation
No. of patients
with Q fever
(n = 58)
No. of tested
patients
(n = 980)
Pneumonia 28 444
Flu-like syndrome 15 228
Hepatitis 7 76
Lymphadenopathy 2 118
Pericarditis 2 29
Guillain-Barre 1 36
Osteomyelitis 1 3
Optic neuritis 1 15
Endocarditis 1 31
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